Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer

BACKGROUND: The activation of the MAPK and PI3K/AKT/mTOR pathways is implicated in the majority of cancers. Activating mutations in both of these pathways has been described in colorectal cancer (CRC), thus indicating their potential as therapeutic targets. This study evaluated the combination of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitts, Todd M., Newton, Timothy P., Bradshaw-Pierce, Erica L., Addison, Rebecca, Arcaroli, John J., Klauck, Peter J., Bagby, Stacey M., Hyatt, Stephanie L., Purkey, Alicia, Tentler, John J., Tan, Aik Choon, Messersmith, Wells A., Eckhardt, S. Gail, Leong, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234626/
https://www.ncbi.nlm.nih.gov/pubmed/25401499
http://dx.doi.org/10.1371/journal.pone.0113037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234626/
https://www.ncbi.nlm.nih.gov/pubmed/25401499
http://dx.doi.org/10.1371/journal.pone.0113037

Ejemplares similares